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To the Editor: Because of the ease in its determina-
tion, the serum creatinine concentration (Scr) has been
used as a quantitative marker of renal function in place
of the more time-consuming, but also more accurate,
methods such as the inulin clearance. However, the im-
pact of dietary protein intake on the determination of The homocysteine confusion:Scr, even by newer enzymatic techniques, remains unap-
preciated. A previous report described elevations in the Now, more is better?Scr in healthy volunteers after ingestion of beef [1]. How-
ever, the technique used for Scr determination, the Jaffe
method, is affected by noncreatinine chromogens, and To the Editor: After reading the paper by Wrone et
may give falsely elevated values compared to the more al in a recent issue of Kidney International regarding
sensitive enzymatic assays. We studied the effect of ani- methylenetetrahydrofolate reductase (MTHFR) variant
mal protein intake on Scr, as determined by the Ektachem and cardiovascular disease (CVD) in renal patients [1]
700XRC analyzer using a 2-point rate creatinine assay we have some concerns we would like to express.
performed at 37 (Johnson and Johnson Clinical Diag- First, it is troubling to accept that the TT genotype is
nostics, Rochester, NY, USA) in five healthy adult volun- bad, but high serum homocysteine is good. The sentences
teers (mean age, 43 years). “TT genotype is associated with hyper-homocysteinemia”
A baseline Scr was obtained followed by the intake of and “suggests a lifetime of abnormal homocysteine me-
300 g of animal protein of different sources at 1-week tabolism,” are confirmed in studies measuring homocys-
intervals (cooked beef stew, turkey breast and ham). teinemia before any vitamin supplementation, as in our
Three hours after the protein intake, a repeat Scr was 136 patients (Fig. 1A). Therefore, if Wrone et al conclude
obtained. We found that the mean Scr rose by 98.5% that patients “with the TT genotype may benefit the most
(range, 69.2% to 128.6%, P  0.0001, two-tailed paired
from homocysteine reduction,” it seems unacceptable toStudent t test) compared to the baseline Scr after eating conclude that another goal is to keep high homocys-beef. The rise was lower with turkey, although still sig-
teinemia to prevent CVD, as drawn from a logistic re-nificant (16.2%, P  0.0001), and insignificant with ham
gression analysis in which a single determination of a(10.9%, P  0.13).
parameter changing over time should not be used [2], andWe concluded that the Scr, even as determined by
crucial parameters such as phosphorus and parathyroidthe newer enzymatic methods, is influenced by dietary
hormone are missing [3].protein intake to variable degrees; this rise may be even
Second, the duration of dialysis of their patients (3.5more exaggerated in patients with renal disease. We,
4 to .9  4.7 years) is probably too short to allow thetherefore, suggest that in the absence of more data, the
conclusion that “The presence of TT genotype impairsScr, especially in a research study setting, should be mea-
survival in [end-stage renal disease] ESRD patients.”sured in the fasting state in all patients.
This assumption is not confirmed in our patients who
Lavjay Butani, Martin S. Polinsky, have had a longer duration of dialysis (Fig. 1B). As
Bruce A. Kaiser, and H. Jorge Baluarte MTHFR mutation might be related to longevity [4], its
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role in ESRD has not yet been clarified.
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Fig. 1. Serum homocysteine values. (A) In
136 white patients on chronic dialysis (85 men,
51 women, age, 61  14 years) at baseline
(before any vitamin supplementation) and 6
months after vitamin supplementation (vita-
min B12, 1000 to 3000 g/week plus folic acid
15 mg/week). Patients bearing the TT geno-
type (N  22; 16%) and never treated with
vitamin therapies showed outstandingly higher
serum homocysteine values as compared with
patients with TC (N 67; 49%) and CC (N
48; 35%) genotypes. (B) Proportion of study
patients by dialysis period in 136 white patients
(85 males, 51 females, age 61  14 years) in
whom the duration of dialysis was 8.3  8.4
years (minimum 0.6 year, maximum 33 years).
Dialysis period is the year-subgroup of duration
of dialysis. The percentage of TT homozygous
in those with duration of dialysis of greater
than 20 years was higher (18%) than in those
with duration of dialysis 5 years (13%).
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